FDA Investigator Karen K Moksnes

Karen K Moksnes has inspections in 3 countries as of 24 Mar 2023. Karen K Moksnes has collaborated with a combinined 651 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
9
Last Inspection Date:
24 Mar 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100006697
Country:
Denmark, India, China
Co-Investigator(s):
Albinus D'sa, PhD, Albinus M D Sa, Andrea A Branche, Ann L Demarco, Ariel Cruz Figueroa, Atul J Agrawal, Dennis Cantellops Paite, Dipesh K Shah, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Geneve M Maxwell, Geneve M Parks, James S Cartwright, Jawaid Hamid, John A Gonzalez, John Dietrick, Justin A Boyd, Justine Tomasso, Kara D Dobbin, Karen Takahashi, Katherine Szestypalow, Kenneth H Williams, Kham Phommachanh, Laurie B Frazier, Liang Zhou, Lisa M Bellows, Lisa M Feola, Pankaj H Amin, Peter E Baker, Regina T Brown, Sangeeta M Khurana, PhD, Sarah M Meng, Sarah M Napier, Stephen D Brown, Steven D Kehoe, Syed N Ali, Thomas E Friel, Yumi J Hiramine

Karen K Moksnes's Documents

Publish Date Document Type Title
November, 2003 EIR Sun Pharmaceutical Industries Limited - EIR, 2004-01-22
May, 2002 EIR Huzhou Zhanwang Pharmaceutical Co., Ltd. - EIR, 2002-07-15
June, 2004 FDA 483 Response Fertin Pharma A/S - Form 483R, 2004-06-26
November, 2003 EIR FDC Limited - EIR, 2004-01-22
May, 2004 FDA 483 Response Steins Laboratorium A/S - Form 483R, 2004-06-24
November, 2003 FDA 483 Response FDC Limited - Form 483R, 2003-12-31
November, 2003 FDA 483 FDC Limited - Form 483, 2003-11-12
June, 2004 FDA 483 Response Fertin Pharma A/s - Form 483R, 2004-07-26
November, 2003 FDA 483 Response Sun Pharmaceutical Industries Limited - Form 483R, 2003-12-05
June, 2004 EIR Fertin Pharma A/S - EIR, 2004-07-13
June, 2004 EIR Fertin Pharma A/s - EIR, 2004-07-14
November, 2003 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2003-11-06
October, 2003 EIR Morepen Laboratories Limited - EIR, 2004-02-10
May, 2002 FDA 483 Response Star Lake Bioscience Co., Inc. Zhaoqing Guangdong Star Lake Bio-chemical Pharmaceutical Factory - Form 483R, 2002-05-09
May, 2004 EIR Steins Laboratorium A/S - EIR, 2004-06-30
October, 2003 FDA 483 Response Morepen Laboratories Limited - Form 483R, 2004-02-11
May, 2002 FDA 483 Response Huzhou Zhanwang Pharmaceutical Co., Ltd. - Form 483R, 2002-06-21
May, 2004 FDA 483 Steins Laboratorium A/S - Form 483, 2004-05-25
May, 2002 FDA 483 Huzhou Zhanwang Chemical Pharmaceutical Co. Ltd. - Form 483, 2002-05-16
May, 2002 EIR Star Lake Bioscience Co., Inc. Zhaoqing Guangdong Star Lake Bio-chemical Pharmaceutical Factory - EIR, 2002-07-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more